HORSHAM, PA. — Ancillare, LP has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries. As Ancillare expands its global footprint into Europe, Middle East, and Africa (EMEA) – their European depot had to be equipped to meet the global needs of our clients. Cathy Porretti, Executive Vice President of Global Operations and Information Technology, who is responsible for the daily management for its Master Depot in Milton Keynes, United Kingdom, has been working diligently on the global distribution strategies of clinical and ancillary supplies.

In early February, Ancillare announced the appointment of Executive Vice President, Global Clinical Development, Gurinder Shinmar, whose focus will be driving the global expansion in EMEA and APAC regions with the Ancillare Turn-Key Operation (A-TKO™) model as a solution for study sponsors and CROs with complex, global clinical trials. As new opportunities are brought to fruition by the Global Clinical Development team, Porretti’s team will be prepared to execute.

“Cathy has been key to the ongoing success of our United Kingdom depot and with Brexit on the horizon, Ancillare is making every effort to prepare for the unknown,” said Joanne Santomauro, Ancillare’s Chief Executive Officer “We believe her ongoing oversight of our United Kingdom daily operations will allow us to maximize Gurinder’s time and energy in service to both current, and prospective, sponsor and CRO Executive Leadership teams.”

According to Santomauro, both roles, will allow for our clients to realize a more seamless transition from onboarding and protocol design to execution and day-to-day support. Porretti, who has served in a Global Operations Executive Leadership capacity for nearly 30 years, and has been instrumental to Ancillare’s rapid growth since its inception in 2006.

About Ancillare, LP

Ancillare is the only organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit Ancillare.com.